"Plasminogen Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.
| Descriptor ID |
D010960
|
| MeSH Number(s) |
D08.811.277.656.300.760.635 D08.811.277.656.959.350.635 D12.776.124.125.662
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Plasminogen Activators".
Below are MeSH descriptors whose meaning is more specific than "Plasminogen Activators".
This graph shows the total number of publications written about "Plasminogen Activators" by people in this website by year, and whether "Plasminogen Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 3 | 0 | 3 |
| 1999 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plasminogen Activators" by people in Profiles.
-
Pulido JS, Bakri SJ, Valyi-Nagy T, Shukla D. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. Retina. 2007 Oct; 27(8):1071-3.
-
Borrillo JL, Regillo CD. Treatment of subretinal hemorrhages with tissue plasminogen activator. Curr Opin Ophthalmol. 2001 Jun; 12(3):207-11.
-
Mahoney MG, Wang ZH, Stanley JR. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol. 1999 Jul; 113(1):22-5.
-
Gude RP, Binda MM, Presas HL, Klein-Szanto AJ, Bonfil RD. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline. J Biomed Sci. 1999 Mar-Apr; 6(2):133-41.
-
Hollander JE, Wilson LD, Leo PJ, Shih RD. Complications from the use of thrombolytic agents in patients with cocaine associated chest pain. J Emerg Med. 1996 Nov-Dec; 14(6):731-6.
-
Ragni M, Cirillo P, Pascucci I, Scognamiglio A, D'Andrea D, Eramo N, Ezekowitz MD, Pawashe AB, Chiariello M, Golino P. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation. 1996 May 15; 93(10):1913-8.
-
Hartmann JR, McKeever LS, O'Neill WW, White CJ, Whitlow PL, Gilmore PS, Doorey AJ, Galichia JP, Enger EL. Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial. J Am Coll Cardiol. 1996 Jan; 27(1):60-6.
-
Sobel MI, Winkel CA, Macy LB, Liao P, Bjornsson TD. The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):801-8.
-
Jensen PJ, Rodeck U. Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-alpha/EGF receptor. J Cell Physiol. 1993 May; 155(2):333-9.
-
Bjornsson TD, Schneider DE, Berger H. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther. 1989 Jul; 250(1):154-61.